NCT04629729 2025-12-11FT819 in Subjects With B-cell MalignanciesFate TherapeuticsPhase 1 Active not recruiting54 enrolled
NCT02996773 2025-11-10Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineUniversity of ArizonaPhase 1 Completed50 enrolled
NCT01352312 2025-04-29Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and LymphomaThomas Jefferson UniversityPhase 1 Terminated10 enrolled
NCT04245722 2023-10-26FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal AntibodiesFate TherapeuticsPhase 1 Terminated98 enrolled
NCT02194374 2017-06-12Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)M.D. Anderson Cancer CenterPhase 1 Withdrawn